IASO BIOMED, INC.
IASO BIOMED, INC. (IASO): 1 pipeline candidate · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
0.8 months
D/E -1.01 · 0% dilution
Lead: Preclinical
1 candidate
N/A
N/A
A transparent, data-derived signal for IASO BIOMED, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$3K
Quarterly Burn
$17K
Runway
0.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| ias-167a | Preclinical |
Frequently asked questions
How many drug candidates are in IASO BIOMED, INC.'s pipeline?
IASO BIOMED, INC. (IASO) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is IASO BIOMED, INC.'s lead drug candidate?
IASO BIOMED, INC.'s most advanced tracked candidate is ias-167a (Preclinical) for hypogonadism.
What is IASO BIOMED, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, IASO BIOMED, INC. has approximately 0.8 months of cash runway.
Get the full picture on IASO BIOMED, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.